补体C3的细胞内传感激活了细胞自主免疫
Jerry C H Tam1, Susanna R Bidgood1, William A McEwan1
1Medical Research Council Laboratory of Molecular Biology, Division of Protein and Nucleic Acid Chemistry, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK.
细胞通过补充C3检测入侵的病原体,如病毒和细菌,从而触发免疫反应和降解. 某些病毒会分裂C3,但抗病毒药物可以恢复这种防御机制.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 病毒学 病毒学
背景情况:
- 病原体必须克服细胞屏障以建立感染.
- 细胞内病原体检测对于有效的宿主防御至关重要.
- 补体系统是先天免疫的关键组成部分,主要以细胞外作用.
研究的目的:
- 研究补充C3在细胞内病原体检测中的作用.
- 阐明由细胞内C3.3激活的信号通路.
- 确定病原体逃避细胞内补充感应的机制,并探索潜在的治疗干预措施.
主要方法:
- 使用光显微镜追踪病原体的进入和C3定位.
- 通过西方抹杀和细胞因子测试分析细胞内信号级联.
- 使用定量PCR和蛋白质体活性测定来评估病原体的复制和降解.
- 研究病毒蛋白酶和抗病毒化合物对C3功能的影响.
主要成果:
- 携带共附着补充C3进入细胞醇的病原体会立即触发细胞内信号.
- 细胞质C3激活了依赖于线粒体抗病毒信号传递 (MAVS) 的途径,诱导了促炎性细胞因子分泌.
- C3标志着细胞内病原体进行蛋白质体降解,抑制复制.
- 肠道病毒,如犀病毒和脊髓灰质炎病毒,通过3C蛋白酶通过C3分裂而对抗这种系统.
- 抗病毒药物rupintrivir抑制病毒3C蛋白酶,防止C3裂变,并恢复对细胞内补体传感的敏感性.
结论:
- 补充C3作为侵入病原体的细胞内传感器,启动快速免疫反应.
- 细胞内C3介导的感知和降解代表了一种新型的宿主防御机制,可以抵抗病毒和细菌感染.
- 向病毒蛋白酶可以克服病原体逃避策略,使它们易受细胞内补充介导免疫的侵害.
更多相关视频
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
06:54Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
相关概念视频
Complement System
Cell-mediated Immune Responses
Humoral Immune Responses
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
